Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Current evidence clearly demonstrates that coronary artery bypass grafting (CABG) remains the "gold standard" treatment for most patients with multivessel and left main stem disease. This article summarizes the relevant evidence basis demonstrating that CABG, in comparison to stenting, reduces mortality and subsequent myocardial infarction and the need for repeat revascularization. The article also describes the evidence basis to support the use of more arterial grafts during CABG and the current role of off-pump CABG.

Original publication

DOI

10.1007/s11684-014-0374-7

Type

Journal article

Journal

Front Med

Publication Date

12/2014

Volume

8

Pages

395 - 398

Keywords

Coronary Artery Bypass, Coronary Artery Disease, Humans, Treatment Outcome